There are no dead-certs in small-cap investing, but here are some plays that just might rise and shine in 2025.

Investors should ask questions about custodial-based share arrangements by which they do not have legal ownership ...

ASX rallies on commodity boost with BrainChip and DroneShield leading the charge, but 2025 volatility looms with key risks on ...

AI is beginning to influence yet more aspects of regular life, changing how Aussies with the right tech see the Boxing Day ...

ASX rallies on commodity boost as Brainchip and Droneshield soar, while Aussies may have splashed $1.3B on Boxing Day sales.

With two juniors entering trading halts, more gold M&A could be coming in 2024. With prices near record highs, 2025 looks ...

The owner of a fluorspar deposit in northern WA says Japan's Sumitomo could take a 22.5% stake in a $60m JV to develop the ...

Out of 27 IPOs in 2024, two resources plays, an engineering stock, a Mexican food chain and a wool clothing company topped ...

Race Oncology hopes its repurposed drug candidate bisantrene can protect the heart from the dangerous effect of chemotherapy.

Research firm Allens says more M&A activity is expected in 2025, confirming lithium’s positive long-term outlook.

ASX keeps the rally going on Christmas Eve as Avita jumps, St Barbara tanks. Meanwhile Bitcoin dips but 'altcoins' get some ...

Arcadium shareholders approve $10 billion takeover by Rio Tinto, with the mining giant hoping to secure its lithium prize by ...